|
|
Volumn 25, Issue 7, 2007, Pages 910-
|
|
Outcome prediction to erlotinib in gastroesophageal adenocarcinomas: Can we improve epidermal growth factor receptor and phospho-AKT testing? [4]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
EPIDERMAL GROWTH FACTOR RECEPTOR;
ERLOTINIB;
GEFITINIB;
PROTEIN KINASE B;
PROTEIN TYROSINE KINASE INHIBITOR;
PROTEIN KINASE INHIBITOR;
QUINAZOLINE DERIVATIVE;
CHROMOSOME 7;
CORRELATION ANALYSIS;
ESOPHAGEAL ADENOCARCINOMA;
FLUORESCENCE IN SITU HYBRIDIZATION;
GENE AMPLIFICATION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LETTER;
LOWER ESOPHAGUS SPHINCTER;
LUNG SMALL CELL CANCER;
MEDICAL RESEARCH;
METHODOLOGY;
OUTCOME ASSESSMENT;
PREDICTION;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PUBLICATION;
STOMACH ADENOCARCINOMA;
TREATMENT RESPONSE;
TUMOR BIOPSY;
DRUG ANTAGONISM;
ESOPHAGUS TUMOR;
METABOLISM;
NOTE;
PHOSPHORYLATION;
STOMACH TUMOR;
TREATMENT OUTCOME;
ESOPHAGEAL NEOPLASMS;
ESOPHAGOGASTRIC JUNCTION;
HUMANS;
IMMUNOHISTOCHEMISTRY;
IN SITU HYBRIDIZATION, FLUORESCENCE;
PHOSPHORYLATION;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS C-AKT;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
STOMACH NEOPLASMS;
TREATMENT OUTCOME;
|
|
EID: 33947515663
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2006.09.8137 Document Type: Letter |
|
Times cited : (2)
|
|
References (7)
|
